In Vivo Validation of the Mutant Selection Window Hypothesis with Moxifloxacin in a Murine Model of Tuberculosis

por Almeida, Deepak, Nuermberger, Eric, Tyagi, Sandeep, Bishai, William R., Grosset, Jacques
Publicado em 2007

BCG-Mediated Protection against Mycobacterium ulcerans Infection in the Mouse

por Converse, Paul J., Almeida, Deepak V., Nuermberger, Eric L., Grosset, Jacques H.
Publicado em 2011

Treating Mycobacterium ulcerans disease (Buruli ulcer): from surgery to antibiotics, is the pill mightier than the knife?

por Converse, Paul J, Nuermberger, Eric L, Almeida, Deepak V, Grosset, Jacques H
Publicado em 2011

Isoniazid or Moxifloxacin in Rifapentine-based Regimens for Experimental Tuberculosis?

por Rosenthal, Ian M., Zhang, Ming, Almeida, Deepak, Grosset, Jacques H., Nuermberger, Eric L.
Publicado em 2008

Shortening Buruli Ulcer Treatment with Combination Therapy Targeting the Respiratory Chain and Exploiting Mycobacterium ulcerans Gene Decay

por Converse, Paul J., Almeida, Deepak V., Tyagi, Sandeep, Xu, Jian, Nuermberger, Eric L.
Publicado no Antimicrob Agents Chemother (2019)

Powerful Bactericidal and Sterilizing Activity of a Regimen Containing PA-824, Moxifloxacin, and Pyrazinamide in a Murine Model of Tuberculosis

por Nuermberger, Eric, Tyagi, Sandeep, Tasneen, Rokeya, Williams, Kathy N., Almeida, Deepak, Rosenthal, Ian, Grosset, Jacques H.
Publicado em 2008

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

por Almeida, Deepak, Nuermberger, Eric, Tasneen, Rokeya, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy, Peloquin, Charles, Grosset, Jacques
Publicado em 2009

Activities of Rifampin, Rifapentine and Clarithromycin Alone and in Combination against Mycobacterium ulcerans Disease in Mice

por Almeida, Deepak, Converse, Paul J., Ahmad, Zahoor, Dooley, Kelly E., Nuermberger, Eric L., Grosset, Jacques H.
Publicado em 2011

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy

por Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Publicado em 2013

Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

por Gupta, Shashank, Tyagi, Sandeep, Almeida, Deepak V., Maiga, Mariama C., Ammerman, Nicole C., Bishai, William R.
Publicado em 2013

Characterization of Mouse Models of Mycobacterium avium Complex Infection and Evaluation of Drug Combinations

por Andréjak, Claire, Almeida, Deepak V., Tyagi, Sandeep, Converse, Paul J., Ammerman, Nicole C., Grosset, Jacques H.
Publicado no Antimicrob Agents Chemother (2015)

Using Bioluminescence To Monitor Treatment Response in Real Time in Mice with Mycobacterium ulcerans Infection

por Zhang, Tianyu, Li, Si-Yang, Converse, Paul J., Almeida, Deepak V., Grosset, Jacques H., Nuermberger, Eric L.
Publicado em 2011

Bactericidal Activity Does Not Predict Sterilizing Activity: The Case of Rifapentine in the Murine Model of Mycobacterium ulcerans Disease

por Almeida, Deepak V., Converse, Paul J., Li, Si-Yang, Tyagi, Sandeep, Nuermberger, Eric L., Grosset, Jacques H.
Publicado em 2013

Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

por Almeida, Deepak V., Converse, Paul J., Omansen, Till F., Tyagi, Sandeep, Tasneen, Rokeya, Kim, Jeongjun, Nuermberger, Eric L.
Publicado no Antimicrob Agents Chemother (2020)

Microbiological, Histological, Immunological, and Toxin Response to Antibiotic Treatment in the Mouse Model of Mycobacterium ulcerans Disease

por Sarfo, Fred Stephen, Converse, Paul J., Almeida, Deepak V., Zhang, Jihui, Robinson, Clive, Wansbrough-Jones, Mark, Grosset, Jacques H.
Publicado em 2013

Mutations in pepQ Confer Low-Level Resistance to Bedaquiline and Clofazimine in Mycobacterium tuberculosis

por Almeida, Deepak, Ioerger, Thomas, Tyagi, Sandeep, Li, Si-Yang, Mdluli, Khisimuzi, Andries, Koen, Grosset, Jacques, Sacchettini, Jim, Nuermberger, Eric
Publicado no Antimicrob Agents Chemother (2016)

Combination Chemotherapy with the Nitroimidazopyran PA-824 and First-Line Drugs in a Murine Model of Tuberculosis

por Nuermberger, Eric, Rosenthal, Ian, Tyagi, Sandeep, Williams, Kathy N., Almeida, Deepak, Peloquin, Charles A., Bishai, William R., Grosset, Jacques H.
Publicado em 2006

Verapamil Increases the Bioavailability and Efficacy of Bedaquiline but Not Clofazimine in a Murine Model of Tuberculosis

por Xu, Jian, Tasneen, Rokeya, Peloquin, Charles A., Almeida, Deepak V., Li, Si-Yang, Barnes-Boyle, Kala, Lu, Yu, Nuermberger, Eric
Publicado no Antimicrob Agents Chemother (2017)

Oxazolidinones Can Replace Clarithromycin in Combination with Rifampin in a Mouse Model of Buruli Ulcer

por Almeida, Deepak V., Omansen, Till F., Li, Si-Yang, Lee, Jin, Grosset, Jacques H., Converse, Paul J., Nuermberger, Eric L.
Publicado no Antimicrob Agents Chemother (2019)

Revisiting Anti-tuberculosis Activity of Pyrazinamide in Mice

por Almeida, Deepak V., Tyagi, Sandeep, Li, Si-Yang, Wallengren, Kristina, Pym, Alexander S., Ammerman, Nicole C., Bishai, William R., Grosset, Jacques H.
Publicado no Mycobact Dis (2014)